Report Description Request For TOC Research Methodology Download Free Sample

Market Snapshot

CAGR:5.72

2023

2032

Source: Market Expertz

Study Period	2019-2032
Base Year	2023
Forcast Year	2023-2032
CAGR	5.72

Gain accurate insights regarding the negative impacts of COVID-19 on all markets and industries

Download Sample Pdf

Report Overview

This report on the plasma protease C1-inhibitors treatment market analyzes the current and future scenario of the global market. Large number of acute HAE patients is increasing the usage of plasma protease C1-inhibitors treatment. Increasing prevalence of rare diseases around the world, promising pipeline drugs and novel therapies, rising investments in innovation of inhibitor drugs and increasing HAE awareness programs are the major drivers of the global plasma protease C1-inhibitors treatment market.
Based on drug class, the market has been segmented into C1-inhibitors (C1-esterase Inhibitor, Recombinant Inhibitor); Kallikrein Inhibitor (Kalbitor); Selective Bradykinin B2 Receptor Antagonist (Firazyr). The drug class market segments have been analyzed based on available approved products, cost-effectiveness, and preference given by the physicians for the treatment of HAE patients.
In 2018, the global Plasma Protease C1-inhibitor Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2026, with a CAGR of xx% during 2019-2026.

This report focuses on the global Plasma Protease C1-inhibitor Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Plasma Protease C1-inhibitor Treatment development in United States, Europe and China.

The key players covered in this study
Shire plc
CSL Limited
Sanquin
Pharming Group N.V.
...

Market segment by Type, the product can be split into
C1-inhibitors
Kallikrein Inhibitor (Kalbitor)

Market segment by Application, split into
Hospital Pharmacies
Independent Pharmacies and Outlets

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Plasma Protease C1-inhibitor Treatment status, future forecast, growth opportunity, key market and key players.
To present the Plasma Protease C1-inhibitor Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Plasma Protease C1-inhibitor Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2026
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Plasma Protease C1-inhibitor Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 C1-inhibitors
1.4.3 Kallikrein Inhibitor (Kalbitor)
1.5 Market by Application
1.5.1 Global Plasma Protease C1-inhibitor Treatment Market Share by Application (2014-2025)
1.5.2 Hospital Pharmacies
1.5.3 Independent Pharmacies and Outlets
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Plasma Protease C1-inhibitor Treatment Market Size
2.2 Plasma Protease C1-inhibitor Treatment Growth Trends by Regions
2.2.1 Plasma Protease C1-inhibitor Treatment Market Size by Regions (2014-2025)
2.2.2 Plasma Protease C1-inhibitor Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Plasma Protease C1-inhibitor Treatment Market Size by Manufacturers
3.1.1 Global Plasma Protease C1-inhibitor Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Plasma Protease C1-inhibitor Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Plasma Protease C1-inhibitor Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Plasma Protease C1-inhibitor Treatment Key Players Head office and Area Served
3.3 Key Players Plasma Protease C1-inhibitor Treatment Product/Solution/Service
3.4 Date of Enter into Plasma Protease C1-inhibitor Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Plasma Protease C1-inhibitor Treatment Market Size by Type (2014-2019)
4.2 Global Plasma Protease C1-inhibitor Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Plasma Protease C1-inhibitor Treatment Market Size (2014-2019)
5.2 Plasma Protease C1-inhibitor Treatment Key Players in United States
5.3 United States Plasma Protease C1-inhibitor Treatment Market Size by Type
5.4 United States Plasma Protease C1-inhibitor Treatment Market Size by Application

6 Europe
6.1 Europe Plasma Protease C1-inhibitor Treatment Market Size (2014-2019)
6.2 Plasma Protease C1-inhibitor Treatment Key Players in Europe
6.3 Europe Plasma Protease C1-inhibitor Treatment Market Size by Type
6.4 Europe Plasma Protease C1-inhibitor Treatment Market Size by Application

7 China
7.1 China Plasma Protease C1-inhibitor Treatment Market Size (2014-2019)
7.2 Plasma Protease C1-inhibitor Treatment Key Players in China
7.3 China Plasma Protease C1-inhibitor Treatment Market Size by Type
7.4 China Plasma Protease C1-inhibitor Treatment Market Size by Application

8 Japan
8.1 Japan Plasma Protease C1-inhibitor Treatment Market Size (2014-2019)
8.2 Plasma Protease C1-inhibitor Treatment Key Players in Japan
8.3 Japan Plasma Protease C1-inhibitor Treatment Market Size by Type
8.4 Japan Plasma Protease C1-inhibitor Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Plasma Protease C1-inhibitor Treatment Market Size (2014-2019)
9.2 Plasma Protease C1-inhibitor Treatment Key Players in Southeast Asia
9.3 Southeast Asia Plasma Protease C1-inhibitor Treatment Market Size by Type
9.4 Southeast Asia Plasma Protease C1-inhibitor Treatment Market Size by Application

10 India
10.1 India Plasma Protease C1-inhibitor Treatment Market Size (2014-2019)
10.2 Plasma Protease C1-inhibitor Treatment Key Players in India
10.3 India Plasma Protease C1-inhibitor Treatment Market Size by Type
10.4 India Plasma Protease C1-inhibitor Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Plasma Protease C1-inhibitor Treatment Market Size (2014-2019)
11.2 Plasma Protease C1-inhibitor Treatment Key Players in Central & South America
11.3 Central & South America Plasma Protease C1-inhibitor Treatment Market Size by Type
11.4 Central & South America Plasma Protease C1-inhibitor Treatment Market Size by Application

12 International Players Profiles
12.1 Shire plc
12.1.1 Shire plc Company Details
12.1.2 Company Description and Business Overview
12.1.3 Plasma Protease C1-inhibitor Treatment Introduction
12.1.4 Shire plc Revenue in Plasma Protease C1-inhibitor Treatment Business (2014-2019)
12.1.5 Shire plc Recent Development
12.2 CSL Limited
12.2.1 CSL Limited Company Details
12.2.2 Company Description and Business Overview
12.2.3 Plasma Protease C1-inhibitor Treatment Introduction
12.2.4 CSL Limited Revenue in Plasma Protease C1-inhibitor Treatment Business (2014-2019)
12.2.5 CSL Limited Recent Development
12.3 Sanquin
12.3.1 Sanquin Company Details
12.3.2 Company Description and Business Overview
12.3.3 Plasma Protease C1-inhibitor Treatment Introduction
12.3.4 Sanquin Revenue in Plasma Protease C1-inhibitor Treatment Business (2014-2019)
12.3.5 Sanquin Recent Development
12.4 Pharming Group N.V.
12.4.1 Pharming Group N.V. Company Details
12.4.2 Company Description and Business Overview
12.4.3 Plasma Protease C1-inhibitor Treatment Introduction
12.4.4 Pharming Group N.V. Revenue in Plasma Protease C1-inhibitor Treatment Business (2014-2019)
12.4.5 Pharming Group N.V. Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Plasma Protease C1-inhibitor Treatment Key Market Segments
Table Key Players Plasma Protease C1-inhibitor Treatment Covered
Table Global Plasma Protease C1-inhibitor Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Plasma Protease C1-inhibitor Treatment Market Size Market Share by Type 2014-2025
Figure C1-inhibitors Figures
Table Key Players of C1-inhibitors
Figure Kallikrein Inhibitor (Kalbitor) Figures
Table Key Players of Kallikrein Inhibitor (Kalbitor)
Table Global Plasma Protease C1-inhibitor Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Pharmacies Case Studies
Figure Independent Pharmacies and Outlets Case Studies
Figure Plasma Protease C1-inhibitor Treatment Report Years Considered
Table Global Plasma Protease C1-inhibitor Treatment Market Size 2014-2025 (Million US$)
Figure Global Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Plasma Protease C1-inhibitor Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Plasma Protease C1-inhibitor Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Plasma Protease C1-inhibitor Treatment Market Share by Regions 2014-2019
Figure Global Plasma Protease C1-inhibitor Treatment Market Share by Regions 2014-2019
Figure Global Plasma Protease C1-inhibitor Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Plasma Protease C1-inhibitor Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Plasma Protease C1-inhibitor Treatment Market Share by Manufacturers (2014-2019)
Figure Global Plasma Protease C1-inhibitor Treatment Market Share by Manufacturers in 2018
Table Global Plasma Protease C1-inhibitor Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Plasma Protease C1-inhibitor Treatment Product/Solution/Service
Table Date of Enter into Plasma Protease C1-inhibitor Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Plasma Protease C1-inhibitor Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Plasma Protease C1-inhibitor Treatment Market Size Share by Type (2014-2019)
Figure Global Plasma Protease C1-inhibitor Treatment Market Size Market Share by Type (2014-2019)
Table Global Plasma Protease C1-inhibitor Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Plasma Protease C1-inhibitor Treatment Market Size Share by Application (2014-2019)
Figure Global Plasma Protease C1-inhibitor Treatment Market Size Market Share by Application (2014-2019)
Figure Global Plasma Protease C1-inhibitor Treatment Revenue Market Share by Application in 2018
Figure United States Plasma Protease C1-inhibitor Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Plasma Protease C1-inhibitor Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Plasma Protease C1-inhibitor Treatment Market Share (2018-2019)
Table United States Plasma Protease C1-inhibitor Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Plasma Protease C1-inhibitor Treatment Market Share by Type (2014-2019)
Table United States Plasma Protease C1-inhibitor Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Plasma Protease C1-inhibitor Treatment Market Share by Application (2014-2019)
Figure Europe Plasma Protease C1-inhibitor Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Plasma Protease C1-inhibitor Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Plasma Protease C1-inhibitor Treatment Market Share (2018-2019)
Table Europe Plasma Protease C1-inhibitor Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Plasma Protease C1-inhibitor Treatment Market Share by Type (2014-2019)
Table Europe Plasma Protease C1-inhibitor Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Plasma Protease C1-inhibitor Treatment Market Share by Application (2014-2019)
Figure China Plasma Protease C1-inhibitor Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Plasma Protease C1-inhibitor Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Plasma Protease C1-inhibitor Treatment Market Share (2018-2019)
Table China Plasma Protease C1-inhibitor Treatment Market Size by Type (2014-20189) (Million US$)
Table China Plasma Protease C1-inhibitor Treatment Market Share by Type (2014-2019)
Table China Plasma Protease C1-inhibitor Treatment Market Size by Application (2014-2019) (Million US$)
Table China Plasma Protease C1-inhibitor Treatment Market Share by Application (2014-2019)
Figure Japan Plasma Protease C1-inhibitor Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Plasma Protease C1-inhibitor Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Plasma Protease C1-inhibitor Treatment Market Share (2018-2019)
Table Japan Plasma Protease C1-inhibitor Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Plasma Protease C1-inhibitor Treatment Market Share by Type (2014-2019)
Table Japan Plasma Protease C1-inhibitor Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Plasma Protease C1-inhibitor Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Plasma Protease C1-inhibitor Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Plasma Protease C1-inhibitor Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Plasma Protease C1-inhibitor Treatment Market Share (2018-2019)
Table Southeast Asia Plasma Protease C1-inhibitor Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Plasma Protease C1-inhibitor Treatment Market Share by Type (2014-2019)
Table Southeast Asia Plasma Protease C1-inhibitor Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Plasma Protease C1-inhibitor Treatment Market Share by Application (2014-2019)
Figure India Plasma Protease C1-inhibitor Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Plasma Protease C1-inhibitor Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Plasma Protease C1-inhibitor Treatment Market Share (2018-2019)
Table India Plasma Protease C1-inhibitor Treatment Market Size by Type (2014-2019) (Million US$)
Table India Plasma Protease C1-inhibitor Treatment Market Share by Type (2014-2019)
Table India Plasma Protease C1-inhibitor Treatment Market Size by Application (2014-2019) (Million US$)
Table India Plasma Protease C1-inhibitor Treatment Market Share by Application (2014-2019)
Figure Central & South America Plasma Protease C1-inhibitor Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Plasma Protease C1-inhibitor Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Plasma Protease C1-inhibitor Treatment Market Share (2018-2019)
Table Central & South America Plasma Protease C1-inhibitor Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Plasma Protease C1-inhibitor Treatment Market Share by Type (2014-2019)
Table Central & South America Plasma Protease C1-inhibitor Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Plasma Protease C1-inhibitor Treatment Market Share by Application (2014-2019)
Table Shire plc Company Details
Table Shire plc Revenue in Plasma Protease C1-inhibitor Treatment Business (2014-2019) (Million US$)
Figure Shire plc Revenue Growth Rate in Plasma Protease C1-inhibitor Treatment Business (2014-2019)
Table Shire plc Recent Development
Table CSL Limited Company Details
Table CSL Limited Revenue in Plasma Protease C1-inhibitor Treatment Business (2014-2019)(Million US$)
Figure CSL Limited Revenue Growth Rate in Plasma Protease C1-inhibitor Treatment Business (2014-2019)
Table CSL Limited Recent Development
Table Sanquin Company Details
Table Sanquin Revenue in Plasma Protease C1-inhibitor Treatment Business (2014-2019)(Million US$)
Figure Sanquin Revenue Growth Rate in Plasma Protease C1-inhibitor Treatment Business (2014-2019)
Table Sanquin Recent Development
Table Pharming Group N.V. Company Details
Table Pharming Group N.V. Revenue in Plasma Protease C1-inhibitor Treatment Business (2014-2019)(Million US$)
Figure Pharming Group N.V. Revenue Growth Rate in Plasma Protease C1-inhibitor Treatment Business (2014-2019)
Table Pharming Group N.V. Recent Development
Table Global Plasma Protease C1-inhibitor Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Plasma Protease C1-inhibitor Treatment Market Size Share by Regions (2019-2025)
Figure Global Plasma Protease C1-inhibitor Treatment Market Size Share by Regions in 2025
Figure United States Plasma Protease C1-inhibitor Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Plasma Protease C1-inhibitor Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Plasma Protease C1-inhibitor Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Plasma Protease C1-inhibitor Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Plasma Protease C1-inhibitor Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Plasma Protease C1-inhibitor Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Plasma Protease C1-inhibitor Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Plasma Protease C1-inhibitor Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Plasma Protease C1-inhibitor Treatment Market Size by Product (2019-2025)
Figure Global Plasma Protease C1-inhibitor Treatment Market Size by Product in 2025
Table Global Plasma Protease C1-inhibitor Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Plasma Protease C1-inhibitor Treatment Market Size by Application (2019-2025)
Figure Global Plasma Protease C1-inhibitor Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

RESEARCH METHODOLOGY

A research methodology is a systematic approach for assessing or conducting a market study. Researchers tend to draw on a variety of both qualitative and quantitative study methods, inclusive of investigations, survey, secondary data and market observation.

Such plans can focus on classifying the products offered by leading market players or simply use statistical models to interpret observations or test hypotheses. While some methods aim for a detailed description of the factors behind an observation, others present the context of the current market scenario.

Now let’s take a closer look at the research methods here.

Secondary Research Model

Extensive data is obtained and cumulated on a substantial basis during the inception phase of the research process. The data accumulated is consistently filtered through validation from the in-house database, paid sources as well reputable industry magazines. A robust research study requires an understanding of the overall value chain. Annual reports and financials of industry players are studied thoroughly to have a comprehensive idea of the market taxonomy.

Primary Insights

Post conglomeration of the data obtained through secondary research; a validation process is initiated to verify the numbers or figures. This process is usually performed by having a detailed discussion with the industry experts.

However, we do not restrict our primary interviews only to the industry leaders. Our team covers the entire value chain while verifying the data. A significant number of raw material suppliers, local manufacturers, distributors, and stakeholders are interviewed to make our findings authentic. The current trends which include the drivers, restraints, and opportunities are also derived through the primary research process.

Market Estimation

The market estimation is conducted by analyzing the data collected through both secondary and primary research. This process involves market breakdown, bottom-up and top- down approach.

Moreover, while forecasting the market a comprehensive statistical time series model is designed for each market. Macroeconomic indicators are considered to understand the current trends of the market. Each data point is verified by the process of data triangulation method to arrive at the final market estimates.

Final Presentation

The penultimate process results in a holistic research report. The study equips key industry players to undertake significant strategic decisions through the findings. The report encompasses detailed market information. Graphical representations of the current market trends are also made available in order to make the study highly comprehensible for the reader.

You can also purchase parts of this report. Do you want to check out a section wise price list?

Request for Special Pricing

Personalized Business Report Tailored to Your Requirements

Our expert analysts collaborate directly with you to comprehend your specific needs.
Get data on regions, segments, competitors, and vendors of your choice.
Information is presented in alignment with your exact preferences and formatting.

Request for customization

Ask For Discount

Free Sample Report

"Find new revenue generation opportunities"

Plasma Protease C1 Inhibitor Treatment Market Size, Type Analysis, Application Analysis, End-Use, Industry Analysis, Regional Outlook, Competitive Strategies And Forecasts, 2023-2032